semaglutide make me tired Fatigue: Feeling Weak on Semaglutide Why Semaglutide Can Make You

Urbina et al

FLOW Trial Committees and Investigators PMID: 38785209 Introduction Traditionally, and rightly so, the care of patients with chronic kidney disease (CKD) is centered around approaches that slow disease progression

The key is medical oversight, patient education, and long-term strategy

Clinical Benefits of Microdosing: Reduced Side Effects: Lower starting doses minimize nausea, vomiting, and other gastrointestinal symptoms that can lead to treatment discontinuation Individualized Titration: Ability to make small incremental adjustments based on patient response and tolerance Cost Effectiveness: Extended use of each medication vial, making treatment more accessible Improved Adherence: Better tolerability leads to sustained treatment compliance Dosing Protocols for Microdosing: Research supports starting with doses as low as 0.15 mg per week for compounded semaglutide, with gradual titration based on individual response.[5] The flexible dosing allows providers to find the optimal therapeutic dose for each patient while maintaining safety and efficacy